Bacterial conjugation in the cytoplasm of mouse cells. by Lim, Y.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/70050
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
  Published Ahead of Print 2 September 2008. 
2008, 76(11):5110. DOI: 10.1128/IAI.00445-08. Infect. Immun. 
David H. Figurski and Eric A. Schon
Yin Mei Lim, Ad J. C. de Groof, Mrinal K. Bhattacharjee,
 
Mouse Cells
Bacterial Conjugation in the Cytoplasm of
http://iai.asm.org/content/76/11/5110
Updated information and services can be found at: 
These include:
REFERENCES
http://iai.asm.org/content/76/11/5110#ref-list-1at: 
This article cites 71 articles, 31 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 July 12, 2012 by Universiteitsbibliotheek
http://iai.asm
.org/
D
ow
nloaded from
 
INFECTION AND IMMUNITY, Nov. 2008, p. 5110–5119 Vol. 76, No. 11
0019-9567/08/$08.000 doi:10.1128/IAI.00445-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Bacterial Conjugation in the Cytoplasm of Mouse Cells
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Intracellular pathogenic organisms such as salmonellae and shigellae are able to evade the effects of many
antibiotics because the drugs are not able to penetrate the plasma membrane. In addition, these bacteria may
be able to transfer genes within cells while protected from the action of drugs. The primary mode by which
virulence and antibiotic resistance genes are spread is bacterial conjugation. Salmonellae have been shown to
be competent for conjugation in the vacuoles of cultured mammalian cells. We now show that the conjugation
machinery is also functional in the mammalian cytosol. Specially constructed Escherichia coli strains express-
ing Shigella flexneri plasmid and chromosomal virulence factors for escape from vacuoles and synthesizing the
invasin protein from Yersinia pseudotuberculosis to enhance cellular entry were able to enter 3T3 cells and
escape from the phagocytic vacuole. One bacterial strain (the donor) of each pair to be introduced sequentially
into mammalian cells had a conjugative plasmid. We found that this plasmid could be transferred at high
frequency. Conjugation in the cytoplasm of cells may well be a general phenomenon.
Since the advent of the antibiotic era, the use of antimicro-
bial agents has become routine and is currently widespread in
clinical, veterinary, and agricultural (in both crop and animal
husbandry) settings. Bacterial populations thus face great se-
lective pressure to evolve resistance mechanisms and to dis-
seminate resistance genes. Furthermore, antibiotic treatment
has been shown to result in the overgrowth of resistant bacte-
rial strains, as susceptible normal flora succumb to the effects
of the drug. A hallmark of enteroinvasive pathogenic bacteria
such as Listeria, Salmonella, Shigella, and Yersinia spp. is that
they occupy an intracellular niche, such as vacuoles or the
cytoplasmic space (14), thereby evading the effects of conven-
tional antibiotics that are unable to penetrate the host cell
membrane (19, 35, 42, 53). The cytoplasmic environment of
the host cell is thus an antibiotic-protected niche that intracel-
lular bacteria might employ for the transfer of resistance fac-
tors.
Virulence genes are also often found on horizontally mobile
elements such as plasmids (20), and conjugation is a major
mode of virulence gene transfer between bacteria. It has been
shown that rates of conjugation and horizontal gene transfer
are higher in a biofilm (47), which, like the cytoplasmic space,
is also a niche that protects bacteria from antibiotics (10, 41).
Importantly, biofilm bacteria may exchange virulence and an-
tibiotic resistance genes in this protected environment.
Salmonella enterica serovar Typhimurium is able to ex-
change genetic information in human intestinal cells (20). In
this case, the bacteria are confined within membrane-bound
vacuoles, which essentially serve as extracellular compartments
since the bacteria do not have access to the cytoplasmic space.
Most antibiotics are unable to penetrate vacuoles, and those
that do are rendered ineffective or less effective in the endo-
somal compartments due, for example, to the lower pH in
those compartments (46). For this reason, S. enterica strains
are able to survive, multiply (62), and even conjugate (20) in
these compartments. However, it is currently unknown whether
conjugation can take place in the cytosol of mammalian cells.
This issue is highly relevant to bacteria such as Listeria mono-
cytogenes (3) and Shigella flexneri (58), extremely pathogenic
bacteria that have developed strategies to evade the host de-
fense mechanism of phagosomal killing by entering cells via the
endocytic pathway and then escaping from the phagosome into
the cytosol.
Using EcSf2a-3, an avirulent Escherichia coli-Shigella flexneri
hybrid (2) that is capable of infecting mammalian cells, we
show here that intracytoplasmic bacteria can conjugate in the
cytosol of mammalian cells.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this
work are described in Tables 1 and 2. IncP plasmid RK2 encodes conjugation
factors and kanamycin (Km) resistance (Kmr) as well as ampicillin resistance
(Apr) and tetracycline resistance (Tcr) (52, 67). Plasmid pUZ8002 (J. W. Wilson
and D. H. Figurski, unpublished data) is a derivative of pUZ8 (Kmr Tcr) (26) that
carries the oriT1 mutation of an RK2 oriT1 derivative. The oriT1 mutation
severely reduces pUZ8 self-transfer by several orders of magnitude (103).
Wild-type pUZ8 self-transfer is similar to that of RK2 because it uses the same
conjugation system found on RK2. The oriT1 mutation reduces self-transfer but
not mobilization. Since self-transfer is not eliminated, rare self-transfer events
can be selected easily (60). Plasmid pGB2inv (23) encodes bacterial invasin
from Y. pseudotuberculosis and confers resistance to spectinomycin (Sp) (Spr).
Consistent with data from previous studies, we found that invasin can convert
noninvasive DH10B into highly penetrant bacteria. Plasmid pACYC184 confers
resistance to chloramphenicol (Cm) (Cmr) (11, 54).
Mammalian cell culture. HeLa human cervix epithelial adenocarcinoma cells
(ATCC CCL-2), HepG2 human hepatocellular carcinoma cells (ATCC HB-
8065), NIH 3T3 mouse embryonic fibroblast-derived cells (ATCC CRL-1658),
and 143B human osteosarcoma-derived cells (ATCC CRL-8303) were cultured
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10032. Phone: (212) 851-5532. Fax: (212) 305-3986. E-mail: eas3
@columbia.edu.
† Y.M.L. and A.J.C.D.G. contributed equally to this work.
‡ Present address: Department of Cell Biology, Nijmegen Centre for
Molecular Life Sciences, Radboud University Medical Centre, Geert
Grooteplein 28, 6525 GA Nijmegen, The Netherlands.
 Published ahead of print on 2 September 2008.
5110
 o
n
 July 12, 2012 by Universiteitsbibliotheek
http://iai.asm
.org/
D
ow
nloaded from
 
in Dulbecco’s modified Eagle medium (DMEM) (catalog number 11995-065;
Invitrogen) supplemented with 10% fetal bovine serum (FBS) (catalog number
26140-079; Invitrogen) and antibiotics (penicillin-streptomycin) (catalog number
15140-122; Invitrogen) at 37°C with 5% CO2. Mouse LR5 macrophage cells (a
kind gift of John Loike, Columbia University) were grown in RPMI 1640 (catalog
number 11875-093; Invitrogen) supplemented with 10% heat-inactivated FBS
and antibiotics. Antibiotics were removed from the culture medium 24 h before
infections.
Bacterial infection of cultured cells. The infection protocol was based on a
previously reported method (21). Mid-log-phase bacterial pellets were resus-
pended in phosphate-buffered saline (125 mM NaCl, 10 mM NaHCO3, 1 mM
NaH2PO4, 5 mM KCl, 2 mM MgSO4, 1.8 mM CaCl2, 10 mM HEPES, and 10
mM glucose [pH 7.4] [PSS]) (16). The numbers of bacteria in liquid culture were
estimated by measurements of the optical density at 600 nm (1 optical density
unit at 600 nm corresponds to 8  108 bacteria/ml), and this value was used to
determine the desired multiplicity of infection (MOI) (target MOIs were 5 for
LR5 cells; 5, 100, and 200 for HeLa cells; 1,000 for HepG2 and 143B cells; and
10, 50, 100, and 1,000 for 3T3 cells). The actual MOI used was determined a
posteriori by plating serial dilutions of this suspension on appropriate selection
plates.
Mammalian cells were cultured without antibiotics for 24 h prior to infection
in DMEM containing 10% FBS (culture medium). On the day of infection,
monolayers were washed once with PSS just before infection. We found that
infection results were most consistent when only the middle two wells of six-well
plates were used and when the cell monolayers were 90% confluent. Bacteria
resuspended in PSS to the desired MOI (typically between 50 and 100 for the 3T3
cells used in the bulk of the experiments) were spun onto the cells for 10 min
(720  g, with no brake) in a plate centrifuge (catalog number 5804; Eppendorf),
followed by incubation at 37°C. Infection was allowed to take place for various
times, as indicated in the schematic of the protocols, and the monolayers were
then washed three times with PSS. The infected cells were then transferred to
37°C with 5% CO2 for 45 min to 6 h in medium containing gentamicin (Gm)
(MediumGm) (DMEM, 20 mM HEPES, 10% FBS, 50 g/ml Gm [catalog
number 15710; Invitrogen]) to kill extracellular bacteria (18, 65).
To determine the efficiency of cellular entry, the cells were washed three times
with PSS and then lysed with ice-cold PSS containing 0.1% Triton X-100 (catalog
TABLE 1. Bacterial strains and plasmids used
Bacterial strain
or plasmid Genetic properties or relevant genotype or phenotype Relevant description Reference or source
Strains
EcSf2a-3 The chromosome is a chimera of E. coli K-12 strain
395-1 (aroD for attenuation) and S. flexneri 2a
strain 256 with a Shigella virulence plasmid
mutant 	pWR100(icsA/virG)
; this strain is
competent for invasion, which requires both
chromosomal and plasmid virulence genes
E. coli-S. flexneri hybrid; harbors the S. flexneri
pWR100 virulence plasmid; taken up
rapidly by 1 integrin-expressing cells;
maximal phagosomal escape; attenuated for
safety; this strain can invade human cells
and escape vacuoles, but because it has a
mutation in icsA/virG, it is unable to move
between cells
2
DH10B F araD139 (ara leu)7697 lacX74 galU galK rpsL
deoR endA1 nupG recA1 mcrA (mrr hsdRMS
mcrBC) (80dlacZM15)
E. coli strain commonly used for molecular
cloning; nonhybrid; lacks pWR100; slow
uptake into cells; minimal phagosomal
escape
22, 49
Plasmids
RK2 IncP Tra Kmr Apr Tcr Transfers itself efficiently; donor plasmid 1, 31, 52
pACYC184 P15A rep Cmr Tcr Nonconjugative plasmid in our experiments
(completely unable to self-transfer and
unable to be mobilized at a detectable
level); marker for recipient bacterium
11
pEGFP-N2 pMB1 rep Kmr gfp Nonconjugative plasmid (completely unable to
self-transfer and unable to be mobilized at
a detectable level) used for its antibiotic
resistance marker
Clontecha
pGB2inv pSC101 rep Spr inv Encodes invasin protein of Y.
pseudotuberculosis, which enables bacteria
to be taken up by 1 integrin-expressing
cells
23
pUZ8002 IncP Tra (oriT1) Kmr Tcr RK2-like, pUZ8 derivative; inefficient self-
transfer (103 compared to the wild type);
used as negative control for the self-
transmissible (donor) plasmid
60; J. W. Wilson and
D. H. Figurski,
personal
communication
pWR100 S. flexneri 5 strain M90T, IncFII (ipa-mxi-spa)
icsA/virG
S. flexneri virulence plasmid, mutated to be a
virG mutant to prevent cell-to-cell
movement. Facilitates rapid and efficient
phagosomal escape
24, 44
a See http://www.clontech.com/images/pt/dis_vectors/PT3053-5.pdf.
TABLE 2. Properties of bacterial strains useda
Bacterial strain (plasmid	s
) Selectionused
Properties
I E C
DH10B(pACYC184) Cmr   
DH10B(pGB2inv, pACYC184) Spr Cmr   
DH10B(pGB2inv, pEGFP-N2) Spr Kmr   
DH10B(RK2) Kmr   
DH10B(pGB2inv, RK2) Spr Kmr   
EcSf2a-3(pACYC184) Cmr   
EcSf2a-3(pGB2inv, pACYC184) Spr Cmr   
EcSf2a-3(RK2) Kmr   
EcSf2a-3(pGB2inv, RK2) Spr Kmr   
EcSf2a-3(pGB2inv, pUZ8002) Spr Kmr   
a I, competence for invasion, i.e., presence of invasin plasmid pGB2inv; E,
competence for vacuolar escape; C, competence for self-transmissibility of the
conjugative plasmid; , high; , low.
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number 07100; International Biotechnologies). The lysates were plated at vari-
ous dilutions in duplicate onto LB agar (Miller formulation, catalog number
BP1425-500; Fisher), selecting for the appropriate antibiotic markers carried by
the invading bacteria (Km sulfate [catalog number K4000-5G], Cm [catalog
number C-1919], and Sp [catalog number S-9007]; Sigma-Aldrich). The CFU
obtained thus correspond to the numbers of bacteria that had gained entry into
the cells (21). The number of bacteria per cell was calculated as follows: (CFU 
dilution factor  volume of lysate)/number of host cells in the monolayer.
To determine the efficiency of vacuolar escape, we employed a chloroquine
(Cq) protection assay. Cq is concentrated in endocytic vesicles (39) and can thus
be used to distinguish between internalized bacteria that remain in vacuoles and
bacteria that are able to exit the vacuole and gain access to the cytoplasmic space
(21). MediumGm containing Cq diphosphate (catalog number C6628; Sigma-
Aldrich) (MediumGmCq) (DMEM, 20 mM HEPES, 10% FBS, 50 g/ml
Gm, and 100 g/ml Cq diphosphate) was added to the monolayers for 45 min
following the infection phase, followed by three washes in PSS, lysis, and plating
as described above. In some cases, the monolayers were treated with Cq prior to
bacterial infection to ensure that the antibiotic was washed away effectively so as
not to interfere with the subsequent bacterial invasion (optional Cq pretreat-
ment) (see Fig. 2A). The percentage of vacuolar escape was calculated as follows:
(number of bacteria recovered with Cq treatment/number of bacteria recovered
in the absence of Cq treatment)  100.
To detect conjugation events in the cytoplasm, two rounds of bacterial infec-
tion were performed (see Fig. 3A). First, donor bacteria were spun onto the cell
monolayer and allowed to invade the cells. MediumGm and then
MediumGmCq were added to kill extracellular and vacuolar bacteria, re-
spectively. The monolayers were washed to remove the antibiotics, followed by a
second round of infection with recipient bacteria. After the second round of Gm
and Cq treatments, the infected cells were incubated for various lengths of time
(1 h to 18 h) to allow conjugation to occur. The culture medium contained a
reduced concentration of Gm (DMEM, 10% FBS, and 5 g/ml Gm [O/N me-
dium]) to prevent extracellular conjugation (in our experiments, the MIC of Gm
was 0.2 g/ml) (data not shown). Cq is toxic to mammalian cells over long
periods (12), so in some cases, the cells were treated for a third time with Cq
immediately prior to lysis to kill any remaining intravacuolar transconjugants
(optional, MediumGmCq for 45 min) (see Fig. 3A). The cells were then
washed three times in PSS, lysed, and plated as described above.
RESULTS
The relevant genotypes and properties of the bacterial
strains and plasmids used in this work are shown in Tables 1
and 2. Briefly, we used bacterial strain EcSf2a-3, which is
competent for both cellular entry and vacuolar escape into the
cytoplasm, and control bacterial strain DH10B, which is com-
petent for neither. EcSf2a-3 and DH10B were transformed
with the following plasmids, as required: pGB2inv (invasin-
encoding plasmid), pEGFP-N2 (marker plasmid for bacteria;
Kmr), and pACYC184 (marker plasmid for recipient bacteria;
Cmr). Plasmids RK2 (self-transmissible, conjugative plasmid;
Kmr) and pUZ8002 (RK2-like, pUZ8 derivative, deficient for
self-transfer; Kmr) were conjugated into these bacteria. Self-
transfer of pUZ8002, although rare, can be selected easily (60).
EcSf2a-3 is deficient for cellular entry but retains cytotoxic
functions. Shigella flexneri is able to induce its own phagocyto-
sis by nonprofessional phagocytic cells, such as the epithelial
cells of the colonic mucosa (“M” cells) and cultured epithelial
cell lines (e.g., HeLa) (58), by expressing virulence genes en-
coded by plasmid pWR100. This plasmid is sufficient to confer
the invasive phenotype upon noninvasive Escherichia coli in
vitro (56). S. flexneri infection of macrophages leads rapidly to
an apoptotic-like death as early as 1 h after infection (71). S.
flexneri penetration of HeLa cells is also efficient: bacteria lyse
the phagocytic membrane and lie free within the cytoplasm in
minutes (58, 64), but unlike infected macrophages, infected
HeLa cells do not undergo apoptosis (43). As opposed to
highly pathogenic S. flexneri, EcSf2a-3 is an avirulent hybrid
bacterial strain carrying chromosomal genes from E. coli and S.
flexneri and the virulence plasmid pWR100 from S. flexneri (2,
50). EcSf2a-3 infection of mouse LR5 macrophage cells led to
apoptosis (data not shown), consistent with results using wild-
type S. flexneri (71). While EcSf2a-3 has also been reported to
invade HeLa cells (2), we found that its levels of cellular entry
were too low (data not shown) to be of use in our experimental
protocol. Thus, compared to S. flexneri, EcSf2a-3 appears to be
deficient in cellular entry but to retain cytotoxic function when
engulfed by professional phagocytic cells.
Invasin enables EcSf2a-3 and DH10B bacteria to enter cul-
tured cells. The Yersinia pseudotuberculosis invasin protein
(Inv) is necessary and sufficient for bacterial invasion into
nonphagocytic cells that express a subset of 1 integrins (32,
33). Since EcSf2a-3 enters cells at an inefficient rate, we intro-
duced the Y. pseudotuberculosis invasin-encoding plasmid,
pGB2inv (23), into EcSf2a-3 cells to see if we could enhance
the rate of cellular entry. The experiment was carried out as
described in the legend of Fig. 1A. Briefly, bacteria were spun
onto mammalian host cell monolayers and incubated for 30 to
180 min before treatment with Gm to eliminate extracellular
bacteria. After 45 to 360 min of Gm treatment, the infected
host cells were lysed and plated onto LB agar containing the
appropriate antibiotic(s) to assay for internalized bacteria. We
found that pGB2inv increased the rate of entry of EcSf2a-3
into 3T3 mouse embryonic fibroblasts by 3 orders of magnitude
(Fig. 1B). Cellular entry rates of E. coli DH10B cells contain-
ing pGB2inv were also increased by 2 to 3 orders of magni-
tude in mouse 3T3 cells (Fig. 1B) as well as in human HepG2
and 143B cells (data not shown). The engulfment rates of the
two bacterial strains were comparable in the cell lines tested
(Fig. 1B). Cellular entry increased with increasing multiplici-
ties of infection (MOI) (Fig. 1B) but not with increasing in-
fection time, holding the MOI constant (data not shown),
implying that MOI is a key factor determining infectivity.
EcSf2a-3 escapes from vacuoles at a high rate. Cq is an
antibiotic that is concentrated within endocytic vesicles (15,
39). The Cq protection assay is used to determine the number
of bacteria that are able to lyse the phagosomal membrane and
escape into the cytoplasmic space (21, 70). We performed this
assay to determine the phagosomal escape efficiencies of our
E. coli strains. The experiment was carried out as described in
the legend of Fig. 1A, with an additional step to perform the
Cq protection assay. Briefly, following treatment with Gm, the
infected cells were incubated in MediumGmCq (Fig. 2A).
EcSf2a-3 bacteria, but not DH10B bacteria, carry S. flexneri
chromosomal genes and S. flexneri virulence plasmid pWR100,
which encodes the “invasin plasmid antigens,” i.e., products of
the ipa gene cluster, necessary for phagosomal escape (5, 9, 44,
57, 59). One of the proteins encoded by the ipa locus, IpaB,
acts as a membrane-lysing toxin, enabling bacterial escape
from the phagocytic vacuole to the cytoplasmic compart-
ment (29). Thus, we expected Ecsf2a-3(pGB2inv), but not
DH10B(pGB2inv), to be able to escape from phagosomes of
3T3 cells into the cytoplasm.
Both DH10B and EcSf2a-3 containing pGB2inv gave com-
parable engulfment rates in 143B and 3T3 cells: in Fig. 1B, the
efficiencies of cellular entry for the two bacterial strains were
comparable for a given MOI and similarly in Fig. 2B, compar-
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ing the numbers of bacteria per cell without Cq for a given
incubation time. For example, DH10B(pGB2inv, RK2) in-
fection of 143B cells resulted in 2.1  101 bacteria per cell,
whereas EcSf2a-3(pGB2inv, RK2) infection of 143B cells
resulted in a comparable 1.3  101 bacteria per cell. Similarly,
DH10B(pGB2inv, pEGFP-N2) infection of 3T3 cells, with a
30-min incubation in MediumGm and a 45-min incubation in
MediumGmCq, resulted in 1.0  100 bacteria per cell,
while EcSf2a-3(pGB2inv, RK2) infection under similar con-
ditions resulted in 1.4  100 bacteria per cell.
However, only EcSf2a-3 was able to escape efficiently from
vacuoles in 143B and 3T3 cells. In Fig. 2B (rows 1 and 2), for
143B cells and under similar experimental conditions, EcSf2a-
3(pGB2inv, RK2) resulted in a fivefold-higher percentage
of Cq resistance, and, thus, of phagosomal escape, than
DH10B(pGB2inv, RK2). (The phagosomal escape percent-
age corresponds to the ratio of the numbers of bacteria recov-
ered with and without Cq treatments.) The difference is more
pronounced in 3T3 cells. The amount of escape for EcSf2a-
3(pGB2inv, RK2) infected into in 3T3 cells (Fig. 2C, black
bars) increased with increasing incubation time in MediumGm,
reaching 30% after 3 h. On the other hand, the amount of
escape for pGB2inv-encoding DH10B infected into 3T3 cells
(Fig. 2C, white bars) was significantly lower, by 1 to 3 orders of
magnitude, and decreased over time (DH10B escape decreases
from 0.42% at 30 min to 0.03% at 180 min [Fig. 2B, rows 1 and
2], while EcSf2a-3 escape increases from 6.1% at 30 min to
30% at 180 min [rows 4 and 8]). The escape data are summa-
rized in Fig. 2C. Note that in these experiments, plasmids
pEGFP-N2 and RK2 were meant to serve only as antibiotic
markers to select for cytosolic bacteria. These particular plas-
mids were used for their markers, and they had no effect on
entry or escape. In the following experiments, we used 3T3
cells as the host cells for infection, as the percentage of pha-
gosome-escaping bacteria was much greater than that with
infection of 143B cells.
Bacteria that gain access to the cytoplasm are able to con-
jugate. We designed an experimental protocol consisting of
two rounds of bacterial infection into mammalian cells to look
for cytosolic conjugation events (Fig. 3A). Briefly, the host cells
were first infected with donor bacteria carrying a self-transmis-
sible (conjugative) plasmid encoding Kmr, followed by infec-
tion with recipient Cmr bacteria. In between the two rounds of
infection, the cells were treated with Gm and Cq to kill extra-
cellular and phagosomal bacteria. In this way, we ensured that
donor and recipient bacteria did not encounter each other
before they gained access to the cytoplasm, thus eliminating
the possibility of conjugation between the two bacterial popu-
lations occurring outside of the cytoplasmic space. Since Gm
does not penetrate the host cell membrane, we knew that we
would be able to wash it away before the second round of
infection. However, Cq is taken up by the mammalian cells, so
we tested whether we could wash Cq out of the cells effectively
to make sure that there was no residual Cq from the first round
of bacterial infection that could interfere with the second
round of infection (with optional Cq pretreatment) (Fig. 2A).
We found that Cq can be washed out of 3T3 cells effectively
and that subsequent bacterial infection and escape were not
affected by multiple Cq treatments (Fig. 2B, last two rows).
Even with Cq treatment, we observed a residual background
level of escape for DH10B(pGB2inv, RK2); however, these
“escape” values decreased over time (Fig. 2B and C), indicat-
ing that we were detecting background events, perhaps be-
cause the bacteria were protected from the drugs in membrane
ruffles and folds (18). In contrast, phagosomal escape reached
30% after 3 h for EcSf2a-3(pGB2inv, RK2) (Fig. 2C). Vac-
uolar escape would presumably have continued to increase
with longer incubation times; however, for reasons of expedi-
FIG. 1. Effect of invasin on infection of 3T3 cells. (A) Scheme of infection protocol. Briefly, confluent monolayers of mammalian cells were
infected with bacteria at various MOIs (MOI of approximately 5 to 1,000, depending on the cell type) (see Materials and Methods for details) for
30 min to 3 h to allow the bacteria to invade the host cells. The infected cells were then incubated in medium containing Gm to kill extracellular
bacteria. At the end of the procedure, the cells were washed and then lysed to release the intracellular bacteria, which were then counted by CFU.
(B) Cellular entry into 3T3 cells of EcSf2a-3 and DH10B with and without invasin. Bacterial entry into 3T3 cells was plotted against the actual
MOIs used (determined a posteriori) (see Materials and Methods for details).
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ency in the double-infection experiments, we incubated cells in
MediumGm for 2 to 3 h prior to Cq treatment (Fig. 3). We
detected conjugation events by assaying for self-transfer of the
donor Kmr plasmid (RK2) into Cmr (pACYC184-containing)
recipient bacteria within the cytoplasm of the host cells to give
easily selectable, doubly resistant, Kmr Cmr transconjugant
bacteria.
Both donor and recipient bacteria carried the non-self-trans-
missible, Sp-resistant invasin plasmid pGB2inv to enhance
cellular entry. In addition, donor bacteria carried the broad-
host-range, self-transmissible plasmid RK2, which confers re-
sistance to Km and sensitivity to Sp and Cm. Recipient bacteria
carried the non-self-transmissible plasmid pACYC184, which
confers resistance to Cm and sensitivity to Sp and Km. When
donor bacteria [e.g., EcSf2a-3(pGB2inv, RK2)] encounter
recipient bacteria [e.g., EcSf2a-3(pGB2inv, pACYC184)],
plasmid RK2 is transferred into the recipients. The resulting
transconjugants [e.g., in this case, EcSf2a-3(pGB2inv, RK2,
pACYC184)] containing plasmid-borne genes conferring resis-
tance to Km and to Cm are able to grow in the presence of
both antibiotics, whereas donor bacteria can grow on medium
containing Km or Km and Sp, and recipient bacteria can grow
on medium containing Cm or Cm and Sp. Neither donors nor
recipients can grow on medium containing both Km and Cm.
FIG. 2. Phagosomal escape. (A) Scheme of infection protocol. Host cell monolayers were infected with bacteria as described in the legend of
Fig. 1A. Following treatment with Gm to kill extracellular bacteria, Cq was added to the medium in half of the wells to kill bacteria that were
retained in the phagosomes. In one set of experiments, the host cell monolayers were pretreated with Cq prior to bacterial infection in order to
verify that the drug can be washed out effectively so as not to interfere with subsequent bacterial infections. The infected cells were washed, lysed,
and plated as described above to determine the percentage of bacteria that were able to escape from phagosomes. (B) Escape of invasin-encoding
EcSf2a-3 and DH10B from vacuoles of 3T3 and 143B cells. Escape ability refers to whether or not the bacterial strain is capable of lysing the
phagosomal membrane to gain access to the host cell cytoplasm. MOIs were determined a posteriori (see Materials and Methods for details) and
were determined once for a set of experiments run at the same time (i.e., on the same day); numbers of experiments are indicated in parentheses
(e.g., MOIs with n  2 indicate that the data were gathered from experiments run on two different days). Incubation times are given for treatment
in MediumGm and MediumGmCq. The numbers of bacteria per cell were calculated as described above (numbers in parentheses indicate
the total numbers of independent experiments performed, with the standard errors of the means [SEM]). The percentage of phagosomal escape
is given by %Cq resistance and was calculated as follows: (number of bacteria recovered with Cq treatment/number of bacteria recovered in the
absence of Cq treatment)  100. The percentages of Cq resistance were calculated for each experiment and then averaged for the reported results.
Note that in these experiments, all bacterial strains contain the invasin plasmid pGB2inv. In addition, the bacteria also contained a second
plasmid, encoding an antibiotic marker to select for cytosolic bacteria. For these experiments, RK2 or pEGFP-N2 was used. (C) Graphical
presentation of escape data for experiments in which host cells were not pretreated with Cq prior to bacterial infection (first eight rows of data
in B). Numbers of experiments are indicated in parentheses; error bars indicate SEM.
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At the end of the experiment, the 3T3 cells were lysed and
spread onto plates with appropriate drug selection to deter-
mine the numbers of donor, recipient, and transconjugant bac-
teria. Samples of media and washes were taken (indicated by
asterisks in Fig. 3A) to check for the presence and amounts of
the various bacterial species; these “intermediate” samples
confirmed our expectations that the washing procedures had
their intended effects of removing extracellular and vacuolar
bacteria (data not shown). Due to the length of the experimen-
tal protocol, it was most convenient to assay for conjugation
about 18 h after infection of cells by the recipient bacteria (i.e.,
overnight), but some assays were performed at earlier time
points (1, 6, and 11 h).
We previously confirmed that the strains used here are com-
petent for conjugation in vitro before proceeding with conju-
gation inside cultured cells (data not shown). We were able to
demonstrate here that conjugation also occurs between bacte-
ria in the cytosol (Fig. 3). The average numbers of transcon-
jugants per donor were initially low (7  104 transconjugants
per donor after 1 h) (not shown) and increased to 7  102 to
9  102 transconjugants per donor at the remaining time
points examined (6, 11, and 18 h) (Fig. 3B and C). We note
that the numbers of EcSf2a-3 donors and recipients present in
the cytosol decreased by an order of magnitude between 6 and
18 h (Fig. 3B). This decline was not the result of host cell death
(data not shown); rather, it was probably due to the fact that
EcSf2a-3 is an aroD mutant. Auxotrophic aroD mutants are
unable to survive for extended periods within the mammalian
cytosol because they require para-aminobenzoic acid for pu-
rine nucleotide biosynthesis, and para-aminobenzoic acid is not
FIG. 3. Intracellular conjugation. (A) Scheme of the intracellular conjugation protocol. Host cell monolayers were first infected with donor
bacteria. The donors were allowed to invade for 30 min before treatment with Gm to eliminate extracellular bacteria, followed by treatment with
Gm and Cq to eliminate bacteria remaining in the phagosomes. The monolayers were then infected with recipient bacteria. After the second
treatment with Gm and Cq, the cells were incubated for various lengths of time (1 h to overnight) to allow conjugation to occur between the
cytosolic donors and recipients. In some cases, the monolayers were treated with Gm and Cq a third time prior to lysis and spreading onto plates
with Km plus Sp to determine the number of cytosolic donors, onto plates with Cm plus Sp to determine the number of cytosolic recipients, and
onto plates with Km plus Cm to determine the number of transconjugants (TC). Asterisks indicate steps in the protocol where media and/or washes
were sampled to check for the presence and amount of relevant bacteria. (B) Tabular presentation of conjugation data. Matings are depicted as
donor  recipient. Conjugation time represents the length of time between the second Cq treatment and the third Cq treatment or lysis. MOIs
and numbers of experiments are as described in the legend of Fig. 2. The numbers of transconjugants per donor were calculated for each
experiment and then averaged for the reported results. (C) Graphical presentation of conjugation data, represented as transconjugants per donor
for EcSf2a-3(pGB2inv, RK2), compared to data for the DH10B(pGB2inv, RK2) control for phagocytic escape. Numbers of experiments are
indicated in parentheses; error bars indicate SEM.
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present in eukaryotic cells (66), nor is it present in the culture
medium. However, due to stores of purine nucleotides and/or
metabolites in both the bacterial cells and the mouse cell
cytoplasm, the bacteria were able to survive and conjugate for
a short period (at least the first 6 h after infection) until those
stores of nucleotides and metabolites were depleted. Our re-
sults imply that conjugation continues to occur even when
nucleotides or metabolites are limiting for vegetative replica-
tion, since the numbers of transconjugants per donor remained
high (7  102 transconjugants) after 18 h, whereas the num-
bers of donors and recipients decreased dramatically (by 2-fold
and 50-fold, respectively). No transconjugants were obtained
in control experiments where 3T3 cells were infected with
EcSf2a-3 bacteria lacking the invasin plasmid and thus defi-
cient for cellular entry (Fig. 3B). Also, physical analyses of the
plasmid DNA from several transconjugants showed that the
plasmids in the transconjugants had the same structures as
the plasmids in the respective donors and recipients (data not
shown).
DH10B bacteria carrying the invasin plasmid were able to
enter cells efficiently, but we expected intracellular DH10B to
remain trapped in vacuoles. However, Cq treatment allowed us
to detect a low level of vacuolar escape of DH10B bacteria.
These bacteria were also competent for conjugation (Fig. 3B
and C). These presumed “escapees” may reflect the back-
ground level of bacterial survival in phagosomes following
treatment with Cq. In our protocol, we omitted Cq from the
medium during incubations greater than 1 h because pro-
longed treatment with Cq is toxic to cells (12). It is formally
possible that some DH10B bacteria may have escaped the two
rounds of Cq treatment and conjugated inside phagosomes,
thus artificially inflating the cytoplasmic conjugation values. To
address this concern, we performed experiments in which Cq
was added a third time, just prior to lysis, to eliminate any
vacuolar transconjugants. We found no significant difference in
conjugation under the two conditions (data not shown), imply-
ing that conjugation was occurring in the cytoplasm and not in
vacuoles. Furthermore, the average number of transconjugants
per donor for EcSf2a-3 (escape-competent bacteria) was more
than 30-fold higher than that for DH10B (escape-incompetent
bacteria) (Fig. 3B) despite having similar conjugation rates in
vitro (data not shown).
Are the Kmr Cmr bacteria the result of conjugation? Some
bacteria exhibit a natural competence for transformation by
naked DNA (34). In our experiments, we observed that there
are bacteria that do not survive in the cytoplasm. Theoretically,
the dead bacteria could release DNA, and some of the Kmr
Cmr bacteria could be transformants as opposed to bona fide
transconjugants. Natural competence for transformation has
not been observed for Escherichia coli or Shigella flexneri in the
laboratory. Moreover, we proved directly that we observed
conjugation, and not transformation, in our experiments by
using a strain of EcSf2a-3 carrying the oriT-defective plasmid
pUZ8002. These bacteria are competent for both invasion and
escape but not for the efficient self-transfer of pUZ8002 by
conjugation. Plasmid pUZ8, from which pUZ8002 is derived, is
almost identical and is highly homologous to RK2; it is thus a
suitable control. In addition, both pUZ8 and RK2 conjugate by
the IncP conjugation system, and their origins of transfer are
identical. Even though the cellular infectivity of donor EcSf2a-
3(pGB2inv, pUZ8002) was similar to that of EcSf2a-
3(pGB2inv, RK2), not a single Kmr Cmr colony was observed
at 18 h when using the conjugation-defective strain (Fig. 3B).
This result implies that in the cytoplasm, transformation with
these bacteria by naked DNA is a very rare event, if it occurs
at all. We conclude that all or nearly all of the Kmr Cmr
bacteria that we observed arose by conjugation.
As the EcSf2a-3(pGB2inv, RK2) strain can conjugate in
vitro (data not shown), another possibility is that the conjuga-
tion that we observed occurred after the lysis of host cells, i.e.,
either in the tube before plating or on the plates before the
lysates were absorbed into the agar. To test this possibility, we
infected one plate of 3T3 cells with donors and another plate
with recipients (followed by Gm and Cq treatment), lysed the
cells on the two plates on ice, and then mixed the lysates and
looked for transconjugants (Fig. 4A). This experiment yielded
a postlysis average background conjugation rate of approxi-
mately 104 transconjugants per donor (Fig. 4B). Thus, any
rates of conjugation above this value should be indicative of
authentic cytosolic conjugation. The conjugation value ob-
tained for EcSf2a-3(pGB2inv, RK2), approximately 7 102
to 9  102 transconjugants per donor, is greater than 2 orders
of magnitude higher, indicating a high rate of genuine cytosolic
conjugation events.
DISCUSSION
While it has been shown that Salmonella enterica serovar
Typhimurium can conjugate in the vacuolar compartments
within host cells (20), to our knowledge, it has never been
demonstrated that conjugation can take place in the cytosol.
Using an Escherichia coli-Shigella flexneri hybrid bacterium ex-
pressing Yersinia pseudotuberculosis invasin, we have shown
here that bacteria can conjugate in the cytosol of mammalian
cells. Our results have implications for antibiotic therapy, for
the evolution of intracellular bacteria, and for new methods to
engineer mammalian cells.
We modified two strains of E. coli (EcSf2a-3 and DH10B)
such that they were taken up rapidly by mammalian cells. The
avirulent vaccine strain EcSf2a-3 is an E. coli strain that con-
tains some virulence genes (both chromosomal and plasmid
borne) from S. flexneri (2). DH10B is a strain commonly used
for molecular cloning (22). We introduced a plasmid encoding
the invasin protein from Y. pseudotuberculosis into both
EcSf2a-3 and DH10B to enable them to enter cells efficiently.
Once inside, only the EcSf2a-3 strains escaped from phagocytic
vacuoles to access the cytoplasm, where we observed high
levels of conjugation. In contrast, the DH10B strains remained
mostly in the endosomal compartment, and we were able to
detect only a low level of conjugation. Our results show that
bacteria can exchange an antibiotic resistance plasmid in the
cytosol of infected cells.
The extent to which cytoplasmic conjugation is a general
phenomenon remains to be established, but it may well extend
to other intracellular bacteria and host cells. The levels of
cytoplasmic conjugation could be higher in cells that are the
natural targets for pathogens. The invasion of those cells
should be common, e.g., epithelial cells of the colonic mucosa
(25). Although we did not look for cytosolic conjugation be-
tween wild-type shigellae, it is possible that virulence factors in
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wild-type S. flexneri that are not expressed in the avirulent
strain EcSf2a-3 used here may result in more frequent and
faster vacuolar escape. Thus, conjugation between wild-type S.
flexneri in the cytoplasm may be more frequent than in
EcSf2a-3. On the other hand, virG allows S. flexneri to move
quickly from one cell to another, reducing the amount of time
spent in the original cell. This ability might lower the rate of
cytosolic conjugation between S. flexneri strains compared to
that of the “trapped” EcSf2a-3 virG mutant. Nevertheless,
there is good reason to believe that conjugation can occur with
natural intracellular pathogens. We note that obligate intra-
cellular pathogens such as the Rickettsia spp. (51) harbor con-
jugative plasmids and transposons (55). Also, F-like plasmids
are able to avoid natural barriers to horizontal gene transfer in
diverse ecological niches (48).
The use of antibiotics has become commonplace. Disinfec-
tants are present in the food that we consume, in household
cleaning products, and in items for personal hygiene such as
bactericidal soaps. The overprescription of antibiotics is ram-
pant (61), and antibiotic use in hospital settings is pervasive.
The ability of bacteria to develop and share resistance deter-
minants quickly and to become multiply resistant by exchang-
ing genes is a serious problem. Nosocomial infections with
multiply resistant bacteria are becoming a great concern and
present unique challenges (4, 38). In addition, the administra-
tion of antibiotics at subtherapeutic levels to promote animal
growth (30) and as a prophylactic measure against infection (a
common practice in animal husbandry in North America) (6) is
probably futile and may even exacerbate the severity of infec-
tions caused by pathogenic intracellular bacteria (37).
While antibiotics are necessary to control and prevent the
spread of infection, there are few new antibiotics today. As
more was learned about how different pathogens work, it was
discovered that some bacteria are able to enter the cytoplasm
of host cells. Unfortunately, the cellular cytoplasmic environ-
ment is largely protected from antibiotics (19, 35, 46, 53) be-
cause the drugs either are unable to penetrate the plasma
membrane of cells, are pumped out, or are inactivated intra-
cellularly (e.g., in lysosomes). Therefore, intracellular patho-
genic bacteria have an advantage over free bacteria because
they can evade the effects of antibiotics that are unable to cross
the plasma membrane. To quote Maurin and Raoult (45), “the
intracellular location of several bacteria and fungi has been
known for decades as a critical point to explain failure of antibi-
otic treatment to eradicate these pathogens from host cells.”
Because conjugation can mobilize any gene, our results infer
that a gene that encodes an antibiotic resistance or virulence
factor can be transferred in the cytosol. Many antibiotic resis-
tance and virulence determinants are plasmid encoded (36),
which contributes to their spread and evolution via horizontal
FIG. 4. Assay for postlysis conjugation. (A) Scheme of infection protocol. Donor and recipient bacteria were infected into separate monolayers
and allowed to invade the host cells. The infected cells were then treated with Gm and Gm then Cq, followed by lysis, as was done earlier. The
donor-infected lysates were mixed on ice with the recipient-infected lysates and then plated with selection for donors, recipients, and transcon-
jugants in order to determine the background conjugation rate during the processing steps after cell lysis. Asterisks are as described in the legend
of Fig. 3. (B) Tabular presentation of the postlysis conjugation data. Matings are depicted as donor  recipient. MOI and numbers of experiments
are as shown in Fig. 2. The numbers of transconjugants per donor were calculated for each experiment and then averaged for the reported results.
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gene transfer. Furthermore, antibiotics that are unable to be
effective inside cells provide protection against surface patho-
gens but not against intracellular pathogens. Moreover, as
plasmids can be received and transmitted by “dead” bacteria
during antibiotic treatment (27), developing antibiotics that
merely target the biofilm or intracellular space is insufficient to
halt the spread of resistance elements. Thus, for the more
effective treatment of intracellular bacterial infections and to
prevent gene exchange within the cytoplasm, it would be of
value to develop antibiotics that act intracellularly and target
the conjugation machinery itself, underscoring the need to
understand the conjugation process as it occurs within host
cells. We currently lack antibiotics that can penetrate cells
effectively and act on intracellular organisms. Furthermore,
bacteria that are killed by antibiotics can still conjugate with
other bacteria (27). Further study of gene transfer in this niche
will help us understand the conditions under which antibiotic
resistance and virulence genes are transferred. Additional re-
search will also assist in the development of better antimicro-
bial agents and new strategies for treatment.
Bacterial conjugation inside eukaryotic cells may provide an
effective method for introducing foreign DNA into mammalian
cells. It may be possible to use intracytoplasmic bacteria to
deliver large pieces of DNA to the nucleus or to mitochondria/
chloroplasts via conjugation. In this regard, we note that mi-
tochondria have been observed in close proximity to S. flexneri
within the cytosol of infected cells, and in many cases, mem-
brane-to-membrane contact was observed (13, 43). Conjuga-
tive plasmids provide donor bacteria with all the protein fac-
tors for the mobilization and transfer of DNA from donor to
recipient. As a consequence, conjugation is not restricted to
prokaryotic recipients. Some donor bacteria can conjugate
with other cell types (40). Conjugation is already a mechanism
for the interkingdom exchange of genetic information. Inter-
kingdom conjugation by bacteria has been demonstrated not
only in plants (7, 40) but also in yeast (28), in mammalian cells
(68), and in mitochondria isolated from mouse cells (69). DNA
has been introduced successfully into fungal and plant mito-
chondria (8, 17, 63). However, there are currently no practical
methods for introducing exogenous DNA into mammalian mi-
tochondria in a stable and heritable manner. The design of an
avirulent bacterium that is capable of conjugation in the cy-
tosol opens up the possibility of transferring DNA across in-
tracellular membranes of organelles such as mitochondria,
chloroplasts, and nuclei.
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